Home Based Infusions for Ocrelizumab
NCT04650321
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Ocrelizumab at home
Sponsor
University of Colorado, Denver
Collaborators
[object Object]